The College of American Pathologists (CAP) released updates to the CAP Cancer Protocols, clinical guidance for reporting pathologic features in the treatment of cancer patients.
The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.
The College of American Pathologists (CAP) earned reapproval from the Centers for Medicare & Medicaid Services (CMS) as an accreditation organization for clinical laboratories.
The College of American Pathologists (CAP), the world’s largest organization for the doctors who diagnose and study disease, recognized several of its members for their dedication to and advancement of pathology and laboratory medicine at the organization's CAP20 Virtual annual meeting.
The College of American Pathologists (CAP) has appointed Alain C. Borczuk, MD, FCAP, chief of thoracic pathology and professor of pathology at Weill Cornell Medicine in New York, to serve as editor-in-chief of CAP’s peer-reviewed publication, Archives of Pathology and Laboratory Medicine.
The College of American Pathologists (CAP), in response to continued patient needs in the global COVID-19 pandemic, released a new proficiency testing (PT) program for the detection of antigens of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Pathologists examine whether mother-to-infant (vertical) transmission of SARS-CoV-2 occurs and, if it does, whether it develops in the uterus prior to delivery, and how it happens in a new research article published in the Archives of Pathology & Laboratory Medicine.
The College of American Pathologists (CAP) released the 2020 edition of its Laboratory Accreditation Program checklists on June 4, 2020. CAP inspectors use the checklists, with approximately 3,000 requirements, during inspections to ensure laboratories comply with the Centers for Medicare and Medicaid Services (CMS) regulations and achieve accreditation.
The College of American Pathologists (CAP) released a new evidence- based guideline “Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies” to clarify procedures and methods to optimize test outcomes.
The College of American Pathologists (CAP), in response to the coronavirus disease (COVID-19) pandemic, released a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).
The CAP's Archives of Pathology & Laboratory Medicine published an analysis of pregnant women with COVID-19 and the health of their infants, authored by David A. Schwartz, MD. FCAP.
Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types.
The College of American Pathologists (CAP) and the American Society of Clinical Oncology (ASCO),have updated the guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer.
The College of American Pathologists (CAP), in collaboration with the American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API), is updating its 2013 guideline “Validating Whole Slide Imaging for Diagnostic Purposes in Pathology.”
The foundation for the Accreditation of Cellular Therapy (FACT) has approved the College of American Pathologists (CAP) as their accrediting organization for laboratories providing histocompatibility services for cellular therapy transplant patients.
The College of American Pathologists (CAP) introduces a streamlined testing strategy, using an algorithm to improve diagnosis of celiac disease, helping millions of Americans
An expert panel assembled by the College of American Pathologists (CAP) is developing an evidence-based clinical practice guideline that aims to reduce variability, identify optimal testing, and improve the accurate diagnosis of patients with monoclonal gammopathies (MGs).
The College of American Pathologists (CAP) today published the first-ever evidence-based clinical practice guideline to help laboratories use quantitative image analysis (QIA) in HER2 immunohistochemistry (IHC) testing for breast cancer. The guideline was published in an early online edition of the Archives of Pathology & Laboratory Medicine.
The Centers for Disease Control and Prevention (CDC) awarded the College of American Pathologists (CAP) a five-year, $300,000/year collaborative grant to further address standardization and support for diagnostic cancer and biomarker electronic reporting.
The future of pathology and improved diagnosis is here. Join us at the College of American Pathologists’ annual meeting CAP18 where new technology and techniques will be shared in the practice of pathology, diagnosis, and treatment. From digital pathology, artificial intelligence, and biomarker testing to liquid biopsies and the importance of having a pathologist on a patient-centered medical diagnostic team, get the latest information patients need to know.
The College of American Pathologists (CAP) published the 2018 edition of its accreditation program checklists on August 22, 2018, providing medical laboratories a blueprint for maintaining compliance with the Centers for Medicare and Medicaid Services (CMS) regulations.
Use of tests that assess genomic variants in circulating tumor DNA (ctDNA) is on the rise. A new joint review from the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) provides an assessment of evidence on ctDNA tests in oncology.
Certain head and neck cancers that are positive for high-risk types of human papillomavirus (HPV) have a better prognosis and may need less aggressive treatment.
Northfield, Ill.—The College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists, will honor five physicians for their service to the CAP organization that helps ensure safety and accuracy within the medical laboratory and the pathology specialty that is responsible for the study and diagnosis of disease.
Northfield, Ill.— Because 70 percent of medical decisions begin with the findings of a pathologist, these physicians are a crucial part of a patient’s care team who touch almost every part of medicine.
Northfield, Ill.—The College of American Pathologists (CAP), the world’s largest association of board-certified pathologists, will honor six doctors with the CAP Lifetime Achievement Award for their service to the organization and to the medical specialty that is responsible for the study and diagnosis of disease, as well as the oversight of medical laboratories.
The College of American Pathologists (CAP) Foundation, the philanthropic arm of the world’s largest association of board-certified pathologists, will award six junior member physicians with the CAP Foundation Leadership Development Award and the CAP Foundation Informatics Award for their involvement with the organization and dedication to the specialty.
Northfield, Ill.— Four physicians who have affected positive change in pathology and patient care have been selected for prestigious recognition at the College of American Pathologists’ (CAP) 2017 annual meeting. These doctors have been essential in advancing the interests of pathology, the science of the causes and effects of disease, as well as laboratory science in general.
The College of American Pathologists (CAP) released on August 21, 2017, the 2017 edition of its Laboratory Accreditation Program checklists. The checklists contain approximately 3,000 requirements that are used during laboratory accreditation inspections to help laboratories stay in compliance with the Centers for Medicare and Medicaid Services (CMS) regulations.
The College of American Pathologists (CAP) releases its Annual Report, which details improvement to patient care, advances in pathology, and CAP member services
The College of American Pathologists Invites Public Comment on Guideline for Quantitative Image Analysis (QIA) of HER2 Immunohistochemistry (IHC) for Breast Cancer
A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
Mary Kay Washington, MD, PhD, FASCP, FCAP, and Jaffer A. Ajani, MD, FASCO, offer their clinical insight and brief explanation of the new evidence-based “CAP-ASCP-ASCO HER2 Testing and Clinical Decision-making in Gastroesophageal Adenocarcinoma Guideline.”
CAP President Richard C. Friedberg, MD, PhD, FCAP, attended the Cancer Moonshot Task Force event at the White House. The CAP will participate in the Blood Profiling Atlas project which will seek to establish protocols for collecting and analyzing blood samples in cancer care.